← Open Payments lookup

NATAUSHA SMITH: Open Payments

NPI 1912771056 · KENNETT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$806 in 41 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $614 · 2025 $806

Food & beverage: $806
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$139
E.R. Squibb & Sons, L.L.C.9$136
Alkermes, Inc.6$116
Lundbeck LLC4$105
Otsuka America Pharmaceutical, Inc.5$80
Teva Pharmaceuticals USA, Inc.3$67
Vanda Pharmaceuticals Inc.3$57
Janssen Pharmaceuticals, Inc2$41
ABBVIE INC.2$36
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$28

Products named: INGREZZA, ARISTADA, COBENFY, REXULTI, ABILIFY ASIMTUFII, FANAPT, UZEDY, INVEGA SUSTENNA.

Industry payments across MO — which companies pay providers there.